Regeneron Pharmaceuticals, Inc.
REGN
$718.16
-$26.67-3.58%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -16.90% | -1.18% | 9.87% | 17.41% | 40.07% |
Total Receivables | 9.61% | 9.36% | 11.63% | 2.02% | 6.35% |
Inventory | 19.64% | 17.80% | 14.59% | 11.97% | 7.44% |
Prepaid Expenses | -9.88% | -28.31% | 86.92% | 2.14% | -5.98% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 36.36% | -- | -- |
Total Current Assets | -4.20% | 3.75% | 12.76% | 11.60% | 22.63% |
|
|||||
Total Current Assets | -4.20% | 3.75% | 12.76% | 11.60% | 22.63% |
Net Property, Plant & Equipment | 14.03% | 10.81% | 9.77% | 8.88% | 10.18% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 10.59% | 10.12% | 15.66% | 14.00% | 13.45% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 42.05% | 46.23% | 49.91% | 42.01% | 47.75% |
Total Assets | 14.15% | 16.41% | 17.71% | 14.34% | 13.23% |
|
|||||
Total Accounts Payable | 30.15% | -7.32% | 2.63% | 11.98% | 2.95% |
Total Accrued Expenses | 6.75% | 0.13% | 8.50% | 15.36% | 13.85% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 59.47% | -- | -- | -- | 53.23% |
Total Finance Division Other Current Liabilities | 36.78% | 18.61% | 53.77% | 21.21% | -5.44% |
Total Other Current Liabilities | 36.78% | 18.61% | 53.77% | 21.21% | -5.44% |
Total Current Liabilities | 15.22% | 1.73% | 13.02% | 15.51% | 8.98% |
|
|||||
Total Current Liabilities | 15.22% | 1.73% | 13.02% | 15.51% | 8.98% |
Long-Term Debt | 0.08% | 0.07% | 0.07% | 0.08% | 0.08% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 17.17% | 0.00% | 0.00% | 0.00% | 1.66% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 70.27% | 82.83% | 100.34% | 43.46% | 39.89% |
Total Liabilities | 18.27% | 11.81% | 18.70% | 12.40% | 8.50% |
|
|||||
Common Stock & APIC | 13.23% | 12.90% | 13.12% | 12.69% | 14.12% |
Retained Earnings | 16.19% | 17.83% | 17.22% | 15.99% | 16.96% |
Treasury Stock & Other | -20.05% | -13.53% | -13.06% | -15.20% | -19.35% |
Total Common Equity | 13.02% | 17.75% | 17.44% | 14.88% | 14.60% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 13.02% | 17.75% | 17.44% | 14.88% | 14.60% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 13.02% | 17.75% | 17.44% | 14.88% | 14.60% |
|